Muutke küpsiste eelistusi

E-raamat: Brain, Stroke and Kidney

Edited by , Series edited by
  • Formaat - PDF+DRM
  • Hind: 436,80 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

For nephrologists, neurologists, neurosurgeons, and cardiologists, Toyoda (cerebrovascular medicine, National Cerebral and Cardiovascular Center, Japan) brings together specialists in nephrology, neurology, cardiology, and other disciplines from Europe, Asia, and the US for 13 articles that examine the relationship between the brain, stroke, and kidney, particularly stroke and chronic kidney disease. They examine cerebrorenal interaction and stroke; underlying concepts, including the inhibition of the renin-angiotensin-aldosterone system and obesity and heart failure as a mediator of the cerebrorenal interaction; the risk of clinical and subclinical brain damage in chronic kidney disease patients, with discussion of carotid atherosclerosis in kidney disease, kidney disease and cognitive function, and the risk of stroke; primary prevention of stroke in kidney disease, including the role of 24-hour blood pressure management and preventing stroke and systemic embolism; and acute/chronic management for stroke patients with chronic kidney and end-stage disease, including stroke features and management in dialysis patients, thrombolysis and hyperacute reperfusion therapy, and antiplatelet therapy. Annotation ©2013 Book News, Inc., Portland, OR (booknews.com)
Introduction
Cerebrorenal Interaction and Stroke
1(6)
K. Toyoda
Underlying Concepts for Cerebrorenal Interaction
Inhibition of the Renin-Angiotensin-Aldosterone System for Cerebrorenal Protection
7(8)
H.J. Lambers Heerspink
Obesity and Heart Failure as a Mediator of the Cerebrorenal Interaction
15(9)
A. Jindal
A. Whaley-Connell
J.R. Sowers
Risk of Clinical and Subclinical Brain Damage in Kidney Disease
Subclinical Cerebral Abnormalities in Chronic Kidney Disease
24(11)
H. Yao
Y. Takashima
M. Hashimoto
A. Uchino
T. Yuzuriha
Carotid Atherosclerosis in Kidney Disease
35(7)
Y. Kokubo
Kidney Disease and Cognitive Function
42(16)
M.F. Elias
G.A. Dore
A. Davey
Risk of Stroke in Kidney Disease
58(9)
T. Ninomiya
Primary Prevention of Stroke in Kidney Disease
Role of 24-Hour Blood Pressure Management in Preventing Kidney Disease and Stroke
67(14)
M. Nagai
S. Hoshide
K. Kario
Preventing Stroke and Systemic Embolism in Renal Patients with Atrial Fibrillation: Focus on Anticoagulation
81(11)
Y. Ahmad
G.Y.H. Lip
Management for Stroke in Kidney Disease
Stroke Features and Management in Patients with Chronic Kidney Disease
92(8)
M. Kamouchi
Stroke Feature and Management in Dialysis Patients
100(10)
K. Iseki
Thrombolysis and Hyperacute Reperfusion Therapy for Stroke in Renal Patients
110(9)
T. Hirano
Antiplatelet Therapy for Preventing Stroke in Patients with Chronic Kidney Disease
119(11)
S.J. Kim
O.Y. Bang
Author Index 130(1)
Subject Index 131